The current evidence base for GLP-1 receptor agonist therapy is derived from extensive clinical trial programmes that have established the efficacy and safety of specific, licensed doses
Une inflammation va suivre (dans le cerveau avec des troubles neurologiques divers et dans lintestin avec de la constipation, des ballonnements, des spasmes)
The significant increase in risk is driven primarily by enteric hyperoxaluria, reduced urinary citrate, and lower urine volume. As clinicians continue to monitor outcomes, Wood emphasized that hydration remains one of the simplest and most effective ways for GLP1 users, especially those with a history of stones, to support kidney health.
Effectiveness of combined cognitive stimulation and physical activity interventions on activities of daily living, cognitive function, and physical function in older people with mild cognitive impairment: a systematic review with meta-analysis